Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030

Market Size
$48.36B
MARKET SIZE, 2025
Projected Market Size
$68.93B
MARKET SIZE, 2030
CAGR
7.3%
CAGR (2025-2030)
Forecast Period
2025-2030
FORECAST PERIOD

OVERVIEW

biomaterials Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global biomaterials market, valued at USD 45.15 billion in 2024, stood at USD 48.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 68.93 billion by the end of the period. Biomaterials are specially crafted materials designed to interact safely with biological systems for medical applications. These substances are engineered for biocompatibility with living tissues and support diverse uses, including implants, prosthetics, drug delivery systems, and tissue engineering.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2024): USD 45.15 Billion
    Current Market Size (2025): USD 48.36 Billion
    Forecast Market Size (2030): USD 68.93 Billion
    CAGR (2025–2030): 7.3%
  • SEGMENT LEADERSHIP:
    Fastest-Growing Region: Asia Pacific is the fastest-growing regional segment with a CAGR of 7.8% during the forecast period.
    Fastest-Growing Type: Metallic biomaterials are projected to show the highest CAGR of 7.6% between 2025 and 2030.
    Application Leader: Orthopedic is expected to dominate the global biomaterials market in 2024 with a CAGR of 34.9%.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Leading companies include BASF SE, Celanese Corporation, and Carpenter Technology.
    Emerging companies such as Collagen Solution and Jellatech have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The global biomaterials market is expanding rapidly, driven by the surge in precision-medicine programs and the routine use of biomarker-guided tests in oncology, cardiology, and other complex diseases.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The biomaterials market is emerging with innovative developments and smart applications of technology, processing, and regulations that work in perfect synchrony with precision medicine, tissue-engineered therapies, and complex biologic treatments. The large and ever-expanding patient base across the global healthcare systems, fighting cancer, cardiovascular diseases, musculoskeletal diseases requiring orthopedic interventions, and neurological disorders, is driving the need for superior biomaterials with a proven track record of reliable and durable clinical outcomes through innovative biomaterials in the form of implants, scaffolds, and drug-delivery devices. Clinically proven and automation-friendly products such as bioresorbable polymers, bioactive ceramics, and collagen bioengineered scaffolds are also gaining increasing acceptances, as they enhance procedures, help with personalized and minimally invasive procedures aligned with the regulator and payer communities in developed regions such as Asia Pacific and North America.

biomaterials Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising advancements in smart, biocompatible, and 3D-printed biomaterials
  • Advancements in healthcare facilities and systems
RESTRAINTS
Impact
Level
  • High development and production costs associated with advanced biomaterials
OPPORTUNITIES
Impact
Level
  • Expanding applications in tissue engineering and regenerative medicine
CHALLENGES
Impact
Level
  • Concerns related to biocompatibility, safety, and adverse immune responses

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising advancements in smart, biocompatible, and 3D-printed biomaterials

Innovations in smart biocompatible and 3D-printed biomaterials are driving market growth, yielding improved clinical outcomes through bioresorbable polymers, surface-modified implants, and expanded applications.

Restraint: High development and production costs associated with advanced biomaterials

High development and production costs for advanced biomaterials, along with complex regulatory approvals, limit scalability and market penetration.

Opportunity: Expanding applications in tissue engineering and regenerative medicine

Biomaterials applications in tissue engineering, regenerative medicine, and personalized therapy represent a significant area of growth potential amidst the rising prevalence of chronic diseases.

Challenge: Concerns related to biocompatibility, safety, and adverse immune responses

Biocompatibility issues, immune reactions, and variability in long-term performance pose ongoing hurdles to the widespread adoption.

BIOMATERIALS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Produces biodegradable lactic acid-based biomaterials (PLA and related polymers) used in controlled drug delivery, tissue regeneration, and resorbable implants. Enables biodegradable implant solutions that support tissue healing and reduce long-term foreign body presence.
Manufactures specialty biomaterial polymers for applications in tissue engineering, drug delivery systems, and medical devices. Enhances material performance with tailored degradation rates, mechanical strength, and biocompatibility for varied clinical needs.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The global biomaterials market is a highly interconnected market where material researchers, device makers, biotechnology and medical technology firms, research institutions, and physicians work together for the introduction of novel solutions based on biomaterials in medicine. Manufacturers, along with specialty material suppliers, offer high-performance polymer, metal, ceramic, and natural biomaterials. Contract research organizations, contract development and manufacturing organizations, and academic research facilities assist in preclinical studies, clinical studies, and commercialization for implants, drug delivery systems, and regenerative medicine based on biomaterials. European medical facilities, reference, and reimbursement systems translate clinical confirmations for biomaterials into practical, innovative, precision medicine for Europe on a daily basis through their normal operations.

biomaterials Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

biomaterials Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Global Biomaterials Market, By Type

In 2024, metallic biomaterials dominated due to the wide use of metals in the manufacturing of medical devices for cardiovascular, dental, and orthopedic applications.

Global Biomaterials Market, By Application

In 2024, the orthopedic segment accounted for the largest share of the biomaterials market. Its market leadership can be attributed to the increasing prevalence of orthopedic conditions, such as osteoarthritis, osteoporosis, and musculoskeletal injuries.

REGION

APAC to be fastest-growing region in market during forecast period

In 2024, the APAC region emerged as the fastest-growing in the global biomaterials market, driven by its dense network of academic medical centers, specialized surgical hospitals, and dynamic life-science innovation hubs. A robust pipeline of orthopedic, cardiovascular, dental, and regenerative therapies, paired with significant investments in personalized medicine and extensive clinical trials, fuels this surge.

biomaterials Region

BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX

In the global biomaterials market, BASF leads as the star player, leading the polymer segment with its extensive lineup of medical-grade plastics and superabsorbent materials that hospitals and device OEMs worldwide trust for wound-care dressings, surgical pads, and reliable components in drug-delivery and surgical instruments. Mitsubishi Chemical emerges as a rising leader, building momentum via its specialty metal and biomaterial units that deliver precision alloys, implantable textiles, and polymer scaffolds, enabling MedTech and biopharma partners across key regions to pioneer next-gen cardiovascular, orthopedic, and cell-therapy devices.

biomaterials Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 45.15 Billion
Market Forecast in 2030 (Value) USD 68.93 Billion
Growth Rate CAGR of 7.3 % from 2025-2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Type:
    • Metallic Biomaterials
    • Polymeric Biomaterials
    • Ceramic Biomaterials
    • Natural Biomaterials
  • By Application:
    • Orthopedic
    • Cardiovascular
    • Dental
    • Plastic Surgery
    • Urinary
    • Wound Healing
    • Tissue Engineering
    • Ophthalmology
    • Neurological/Central Nervous System
    • Other Applications
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Related Segment & Geographic Reports Orthopedic Biomaterials Market
North America Biomaterials Market
Europe Biomaterials Market
Asia Pacific Biomaterials Market
Polymeric Biomaterials Market

WHAT IS IN IT FOR YOU: BIOMATERIALS MARKET: REPORT CONTENT GUIDE

biomaterials Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Benchmarking end-user preferences for biomaterial types and applications Mapped how surgeons, interventional cardiologists, and dental specialists prioritize metallic, polymeric, ceramic, and natural biomaterials across orthopedic, cardiovascular, dental, and wound-healing procedures, including trade-offs in handling, longevity, and reimbursement Informs portfolio strategy and clinical-education efforts by showing which biomaterial families are gaining share in each specialty, enabling commercial teams to target the right KOLs, procedures, and indication expansions with differentiated value messages
Identifying outsourcing and partnership opportunities for biomaterial-based device development Mapped leading biomaterials-focused CDMOs and contract manufacturers and OEMs with polymer synthesis, implant forming, sterile packaging, and regulatory-compliant scale-up, highlighting examples such as Corbion, Life Science Outsourcing, Evonik, Regenity, and specialized bioresorbable-device developers. Helps clients prioritize high-value partners for co-development and manufacturing, shortens time-to-market for new implants and scaffolds, and reduces capex by leveraging existing GMP infrastructure purpose-built for advanced biomaterials

RECENT DEVELOPMENTS

  • March 2023 : Celanese Corporation and Alessa Therapeutics have entered a collaboration to combine Alessa’s sustained, localized drug-delivery expertise with Celanese’s VitalDose EVA platform to develop a localized, sustained-release oncology drug-delivery system aimed at reducing systemic side effects for cancer patients
  • April 2023 : Celanese Corporation signed an agreement with Glaukos to supply its VitalDose drug-delivery platform as a key component of Glaukos’ iDose TR, a micro-invasive intraocular implant designed to provide long-duration glaucoma therapy by continuously reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
57
2
EXECUTIVE SUMMARY
 
 
 
 
 
63
3
PREMIUM INSIGHTS
 
 
 
 
 
68
4
MARKET OVERVIEW
Biomaterials market growth fueled by smart innovations and expanding therapeutic applications despite cost challenges.
 
 
 
 
 
71
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
RISING ADVANCEMENTS IN SMART, BIOCOMPATIBLE, AND 3D PRINTED BIOMATERIALS
 
 
 
 
 
 
4.2.1.2
ADVANCEMENTS IN HEALTHCARE SYSTEMS, PHYSICAL INFRASTRUCTURE, AND REIMBURSEMENT FRAMEWORKS
 
 
 
 
 
 
4.2.1.3
GROWING DEMAND FOR BIOMATERIALS IN WOUND HEALING AND PLASTIC SURGERY
 
 
 
 
 
 
4.2.1.4
INCREASING USE OF BIOMATERIALS IN MULTIPLE THERAPEUTIC AREAS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH DEVELOPMENT AND PRODUCTION COST OF ADVANCED BIOMATERIALS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EXPANDING APPLICATIONS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE
 
 
 
 
 
 
4.2.3.2
DEVELOPMENT OF NOVEL BIOMATERIALS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
CONCERNS RELATED TO BIOCOMPATIBILITY, SAFETY, AND ADVERSE IMMUNE RESPONSES
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive pressures and capitalize on biomaterial pricing shifts with strategic insights.
 
 
 
 
 
79
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.2
TRENDS IN GLOBAL BIOMATERIALS MARKET
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
ROLE IN ECOSYSTEM
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025
 
 
 
 
 
 
5.5.2
INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
 
 
 
 
 
 
5.6.2
EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
 
 
 
 
 
 
5.6.3
IMPORT VOLUME FOR HS 7221 (STAINLESS STEEL), 2021–2025
 
 
 
 
 
 
5.6.4
EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), 2021–2025
 
 
 
 
 
 
5.6.5
IMPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025
 
 
 
 
 
 
5.6.6
EXPORT DATA FOR HS CODE 284329 (SILVER), 2021–2025
 
 
 
 
 
 
5.6.7
IMPORT VOLUME FOR HS 284329 (SILVER), 2021–2025
 
 
 
 
 
 
5.6.8
EXPORT VOLUME FOR HS CODE 284329 (SILVER), 2021–2025
 
 
 
 
 
 
5.6.9
IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
 
 
 
 
 
 
5.6.10
EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
 
 
 
 
 
 
5.6.11
IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
 
 
 
 
 
 
5.6.12
EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), 2021–2025
 
 
 
 
 
 
5.6.13
IMPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025
 
 
 
 
 
 
5.6.14
EXPORT DATA FOR HS CODE 3910 (SILICONE), 2021–2025
 
 
 
 
 
 
5.6.15
IMPORT VOLUME FOR HS 3910 (SILICONE), 2021–2025
 
 
 
 
 
 
5.6.16
EXPORT VOLUME FOR HS CODE 3910 (SILICONE), 2021–2025
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
 
 
 
 
 
 
5.10.2
STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
 
 
 
 
 
 
5.10.3
ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF ON BIOMATERIALS MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.11.4.1
NORTH AMERICA
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
MEDICAL DEVICE MANUFACTURERS
 
 
 
 
 
 
5.11.5.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations and patents redefine biomaterials, unlocking future market potential and ecosystem shifts.
 
 
 
 
 
112
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
PRECISION TECHNOLOGIES
 
 
 
 
 
 
6.1.1.2
BIOMIMETICS
 
 
 
 
 
6.1.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
3D BIOPRINTING
 
 
 
 
 
 
6.1.2.2
ELECTROSPINNING
 
 
 
 
6.2
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.3.1
TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025
 
 
 
 
 
 
6.3.2
LIST OF PATENTS
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
6.5
IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
 
 
 
 
 
 
 
 
6.5.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.5.2
CASE STUDIES OF AI IMPLEMENTATION
 
 
 
 
 
 
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
 
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate complex global regulations to align sustainability goals with industry standards and certifications.
 
 
 
 
 
120
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
REGULATORY FRAMEWORK
 
 
 
 
 
 
7.1.3
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
 
 
 
 
 
 
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock buying behavior insights to overcome adoption barriers and meet unmet industry needs.
 
 
 
 
 
127
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM KEY END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
9
BIOMATERIALS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
131
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
METALLIC BIOMATERIALS
 
 
 
 
 
 
 
9.2.1
STAINLESS STEEL
 
 
 
 
 
 
 
9.2.1.1
FAVORABLE MECHANICAL PROPERTIES, CORROSION RESISTANCE, AND COST-EFFECTIVENESS TO DRIVE USAGE
 
 
 
 
 
9.2.2
TITANIUM & TITANIUM ALLOYS
 
 
 
 
 
 
 
9.2.2.1
RISING NUMBER OF JOINT REPLACEMENT PROCEDURES TO AID MARKET GROWTH
 
 
 
 
 
9.2.3
COBALT-CHROME ALLOYS
 
 
 
 
 
 
 
9.2.3.1
LOW COST AND EXCELLENT CORROSION RESISTANCE TO AUGMENT MARKET GROWTH
 
 
 
 
 
9.2.4
SILVER
 
 
 
 
 
 
 
9.2.4.1
TOXIC PROPERTIES AND LOW AESTHETIC TO LIMIT USE OF SILVER IN BIOMATERIAL-BASED PRODUCTS
 
 
 
 
 
9.2.5
GOLD
 
 
 
 
 
 
 
9.2.5.1
EXPANDING APPLICATIONS OF GOLD NANOPARTICLES TO DRIVE DEMAND FOR GOLD BIOMATERIALS
 
 
 
 
 
9.2.6
MAGNESIUM
 
 
 
 
 
 
 
9.2.6.1
BIODEGRADABLE CHARACTERISTICS OF MAGNESIUM TO AID SEGMENT GROWTH
 
 
 
 
 
9.2.7
OTHER METALLIC BIOMATERIALS
 
 
 
 
 
9.3
POLYMERIC BIOMATERIALS
 
 
 
 
 
 
 
9.3.1
POLYMETHYLMETHACRYLATE (PMMA)
 
 
 
 
 
 
 
9.3.1.1
LONG-STANDING CLINICAL RECORD DEMONSTRATING SAFETY AND BIOCOMPATIBILITY TO SPUR MARKET GROWTH
 
 
 
 
 
9.3.2
POLYETHYLENE
 
 
 
 
 
 
 
9.3.2.1
WEAR AND TEAR RESISTANCE OF POLYETHYLENE TO POPULARIZE USAGE IN HIP AND KNEE JOINT REPLACEMENTS
 
 
 
 
 
9.3.3
POLYESTER
 
 
 
 
 
 
 
9.3.3.1
BIODEGRADABLE NATURE AND BIOCOMPATIBILITY TO BOOST USE IN VARIOUS MEDICAL APPLICATIONS
 
 
 
 
 
9.3.4
POLYVINYLCHLORIDE
 
 
 
 
 
 
 
9.3.4.1
HEAVY CHLORINE CONTENT OF POLYVINYLCHLORIDE TO HAMPER MARKET GROWTH
 
 
 
 
 
9.3.5
SILICONE RUBBER
 
 
 
 
 
 
 
9.3.5.1
NON-REACTIVE, STABLE, AND RESISTANT IN EXTREME ENVIRONMENTS AND TEMPERATURES TO DRIVE ADOPTION OF SILICONE RUBBER
 
 
 
 
 
9.3.6
NYLON
 
 
 
 
 
 
 
9.3.6.1
LOW WEIGHT, CORROSION RESISTANCE, AND WIDE APPLICATIONS TO PROPEL MARKET DEMAND
 
 
 
 
 
9.3.7
POLYETHERETHERKETONE
 
 
 
 
 
 
 
9.3.7.1
POLYETHERETHERKETONE TO GAIN POPULARITY AS VIABLE ALTERNATIVE TO METALS
 
 
 
 
 
9.3.8
OTHER POLYMERIC BIOMATERIALS
 
 
 
 
 
9.4
CERAMIC BIOMATERIALS
 
 
 
 
 
 
 
9.4.1
CALCIUM PHOSPHATE
 
 
 
 
 
 
 
9.4.1.1
CLOSE STRUCTURAL AND CHEMICAL RESEMBLANCE TO NATURAL BONE AND TEETH TO DRIVE ADOPTION IN BIOMEDICAL APPLICATIONS
 
 
 
 
 
9.4.2
ZIRCONIA
 
 
 
 
 
 
 
9.4.2.1
BIO-INERTNESS AND LOW WEAR RATE OF ZIRCONIA TO BOOST MARKET ADOPTION
 
 
 
 
 
9.4.3
ALUMINUM OXIDE
 
 
 
 
 
 
 
9.4.3.1
INCREASING USE OF ALUMINUM OXIDE IN HIP REPLACEMENTS AND DENTAL IMPLANTS TO DRIVE MARKET
 
 
 
 
 
9.4.4
CALCIUM SULFATE
 
 
 
 
 
 
 
9.4.4.1
BETTER BIOCOMPATIBILITY AND BIORESORBABILITY TO AUGMENT MARKET ADOPTION
 
 
 
 
 
9.4.5
CARBON
 
 
 
 
 
 
 
9.4.5.1
INCREASING USE OF CARBON NANOFIBERS IN REGENERATIVE MEDICINE AND CANCER TREATMENT TO DRIVE MARKET GROWTH
 
 
 
 
 
9.4.6
GLASS
 
 
 
 
 
 
 
9.4.6.1
RISING NUMBER OF ORTHOPEDIC AND DENTAL PROCEDURES TO FUEL DEMAND FOR GLASS BIOMATERIALS
 
 
 
 
9.5
NATURAL BIOMATERIALS
 
 
 
 
 
 
 
9.5.1
HYALURONIC ACID
 
 
 
 
 
 
 
9.5.1.1
RISING INCIDENCES OF OSTEOARTHRITIS TO DRIVE HYALURONIC ACID BIOMATERIALS MARKET
 
 
 
 
 
9.5.2
COLLAGEN
 
 
 
 
 
 
 
9.5.2.1
HIGH TENSILE STRENGTH TO BE USEFUL IN PLASTIC AND COSMETIC SURGERIES, CARDIOLOGY, OPHTHALMOLOGY, AND DRUG DELIVERY
 
 
 
 
 
9.5.3
FIBRIN
 
 
 
 
 
 
 
9.5.3.1
FIBRIN BIOMATERIALS TO BE USEFUL IN CLINICAL PRACTICE FOR CONTROLLING BLEEDING AND ACCELERATING WOUND REPAIR
 
 
 
 
 
9.5.4
CELLULOSE
 
 
 
 
 
 
 
9.5.4.1
CELLULOSE TO BE USEFUL IN WOUND HEALING, SKIN REGENERATION, AND OPHTHALMOLOGY
 
 
 
 
 
9.5.5
CHITIN
 
 
 
 
 
 
 
9.5.5.1
CHITIN TO ACCELERATE SKIN REGENERATION AND POSSESS HIGH BIOCOMPATIBILITY
 
 
 
 
 
9.5.6
ALGINATES
 
 
 
 
 
 
 
9.5.6.1
USE IN WOUND HEALING, TISSUE ENGINEERING & REGENERATIVE MEDICINE, AND DRUG DELIVERY TO DRIVE ADOPTION
 
 
 
 
 
9.5.7
GELATIN
 
 
 
 
 
 
 
9.5.7.1
LOW COST AND COMPARABLE BIOCOMPATIBILITY OF GELATIN TO FUEL MARKET ADOPTION
 
 
 
 
 
9.5.8
CHITOSAN
 
 
 
 
 
 
 
9.5.8.1
NON-TOXICITY OF CHITOSAN TO INCREASE ADOPTION IN BIOMEDICAL RESEARCH
 
 
 
 
 
9.5.9
SILK
 
 
 
 
 
 
 
9.5.9.1
FLEXIBILITY AND ADHESIVE ABILITIES TO DRIVE USAGE IN WOUND HEALING APPLICATIONS
 
 
 
 
 
9.5.10
OTHER NATURAL BIOMATERIALS
 
 
 
 
10
BIOMATERIALS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 97 Data Tables
 
 
 
 
 
165
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
ORTHOPEDIC
 
 
 
 
 
 
 
10.2.1
JOINT REPLACEMENT
 
 
 
 
 
 
 
10.2.1.1
KNEE REPLACEMENT
 
 
 
 
 
 
 
 
10.2.1.1.1
RISING COUNT OF KNEE REPLACEMENT PROCEDURES GLOBALLY TO DRIVE MARKET GROWTH
 
 
 
 
10.2.1.2
HIP REPLACEMENT
 
 
 
 
 
 
 
 
10.2.1.2.1
HIP & KNEE JOINT REPLACEMENTS TO BE MOST COMMONLY PERFORMED PROCEDURES
 
 
 
 
10.2.1.3
SHOULDER REPLACEMENT
 
 
 
 
 
 
 
 
10.2.1.3.1
INCREASING SHOULDER SURGERIES TO DRIVE PRODUCTION OF IMPLANTS
 
 
 
 
10.2.1.4
OTHER JOINT REPLACEMENT APPLICATIONS
 
 
 
 
 
10.2.2
BIORESORBABLE TISSUE FIXATION
 
 
 
 
 
 
 
10.2.2.1
SUTURE ANCHORS
 
 
 
 
 
 
 
 
10.2.2.1.1
GROWING AWARENESS ABOUT SUTURE ANCHOR DEVICES TO PROPEL MARKET GROWTH
 
 
 
 
10.2.2.2
INTERFERENCE SCREWS
 
 
 
 
 
 
 
 
10.2.2.2.1
GROWING ACL RECONSTRUCTION PROCEDURES TO CONTRIBUTE TO MARKET GROWTH
 
 
 
 
10.2.2.3
MENISCAL REPAIR TACKS
 
 
 
 
 
 
 
 
10.2.2.3.1
RISING SPORTS INJURIES TO FUEL GROWTH IN MENISCAL REPAIR TACKS MARKET
 
 
 
 
10.2.2.4
MESHES
 
 
 
 
 
 
 
 
10.2.2.4.1
WEAR RESISTANCE AND PROPER SHAPING OF BIORESORBABLE IMPLANTS TO INCREASE DEMAND FOR BIORESORBABLE MESHES
 
 
 
10.2.3
SPINE SURGERIES
 
 
 
 
 
 
 
10.2.3.1
SPINAL FUSION
 
 
 
 
 
 
 
 
10.2.3.1.1
INTRODUCTION OF MINIMALLY INVASIVE SPINAL FUSION PROCEDURES AND BETTER CLINICAL OUTCOMES TO DRIVE MARKET GROWTH
 
 
 
 
10.2.3.2
MINIMALLY INVASIVE FUSION
 
 
 
 
 
 
 
 
10.2.3.2.1
LESSER POST-SURGERY PAIN AND FASTER RECOVERY TO DRIVE DEMAND FOR MINIMALLY INVASIVE FUSION PROCEDURES
 
 
 
 
10.2.3.3
MOTION PRESERVATION & DYNAMIC STABILIZATION
 
 
 
 
 
 
 
 
10.2.3.3.1
PEDICLE-BASED ROD SYSTEMS
 
 
 
 
 
 
10.2.3.3.2
INTERSPINOUS SPACERS
 
 
 
 
 
 
10.2.3.3.3
ARTIFICIAL DISCS
 
 
 
10.2.4
FRACTURE FIXATION DEVICES
 
 
 
 
 
 
 
10.2.4.1
BONE PLATES
 
 
 
 
 
 
 
 
10.2.4.1.1
HIGH BIOCOMPATIBILITY OF BIOMATERIALS TO BE AN INTEGRAL COMPONENT OF BONE PLATES
 
 
 
 
10.2.4.2
SCREWS
 
 
 
 
 
 
 
 
10.2.4.2.1
METALLIC BIOMATERIAL SCREWS TO BE EXTENSIVELY USED IN ORTHOPEDIC PROCEDURES
 
 
 
 
10.2.4.3
PINS
 
 
 
 
 
 
 
 
10.2.4.3.1
NONREACTIVE NATURE OF METALLIC BIOMATERIAL PINS TO FAVOR USAGE IN FRACTURE FIXATION
 
 
 
 
10.2.4.4
RODS
 
 
 
 
 
 
 
 
10.2.4.4.1
HIGH RIGIDITY, EASY MOBILITY, AND COST EFFICIENCY TO MAKE RODS PREFERRED FOR FRACTURE FIXATION PROCEDURES
 
 
 
 
10.2.4.5
WIRES
 
 
 
 
 
 
 
 
10.2.4.5.1
WIRES MADE UP OF METALLIC BIOMATERIALS TO HELP TREAT FRACTURES OF SMALL BONES
 
 
 
10.2.5
ORTHOBIOLOGICS
 
 
 
 
 
 
 
10.2.5.1
RISING CASES OF OSTEOARTHRITIS TO DRIVE GROWTH IN VISCOSUPPLEMENTATION MARKET
 
 
 
 
10.3
CARDIOVASCULAR
 
 
 
 
 
 
 
10.3.1
CATHETERS
 
 
 
 
 
 
 
10.3.1.1
SHIFT IN PATIENT PREFERENCE FROM TRADITIONAL OPEN SURGERIES TO MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET
 
 
 
 
 
10.3.2
STENTS
 
 
 
 
 
 
 
10.3.2.1
INCREASING NUMBER OF CORONARY INTERVENTION PROCEDURES TO BOOST DEMAND FOR IMPLANTABLE STENTS
 
 
 
 
 
10.3.3
IMPLANTABLE CARDIAC DEFIBRILLATORS
 
 
 
 
 
 
 
10.3.3.1
GROWING GERIATRIC POPULATION AND RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
 
 
 
 
 
10.3.4
PACEMAKERS
 
 
 
 
 
 
 
10.3.4.1
HIGH PREVALENCE OF BRADYCARDIA TO AID DEMAND FOR PACEMAKERS
 
 
 
 
 
10.3.5
SENSORS
 
 
 
 
 
 
 
10.3.5.1
INCREASING PREVALENCE OF CARDIAC DISORDERS TO BOOST DEMAND FOR CARDIOVASCULAR SENSORS
 
 
 
 
 
10.3.6
HEART VALVES
 
 
 
 
 
 
 
10.3.6.1
GROWING GERIATRIC POPULATION TO INCREASE DEMAND FOR PROSTHETIC VALVES
 
 
 
 
 
10.3.7
VASCULAR GRAFTS
 
 
 
 
 
 
 
10.3.7.1
FOCUS ON RESEARCH ON USE OF BIOMATERIALS IN VASCULAR GRAFTS TO OPEN OPPORTUNITIES FOR MARKET GROWTH
 
 
 
 
 
10.3.8
GUIDEWIRES
 
 
 
 
 
 
 
10.3.8.1
GUIDEWIRES TO BE USED FOR GUIDING CATHETERS AND PLACING STENTS INSIDE THE HEART
 
 
 
 
 
10.3.9
OTHER CARDIOVASCULAR APPLICATIONS
 
 
 
 
 
10.4
OPHTHALMOLOGY
 
 
 
 
 
 
 
10.4.1
CONTACT LENSES
 
 
 
 
 
 
 
10.4.1.1
GROWING CASES OF REFRACTIVE ERRORS AND PREFERENCE FOR CONTACT LENSES OVER SPECTACLES TO DRIVE MARKET GROWTH
 
 
 
 
 
10.4.2
INTRAOCULAR LENSES
 
 
 
 
 
 
 
10.4.2.1
INCREASING PREVALENCE OF CATARACTS TO BOOST NUMBER OF CATARACT SURGERIES PERFORMED
 
 
 
 
 
10.4.3
FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
 
 
 
 
 
 
 
10.4.3.1
INCREASING FUNDING AND RESEARCH ACTIVITIES FOR DEVELOPING BIONIC EYES TO PROPEL SEGMENT GROWTH
 
 
 
 
 
10.4.4
SYNTHETIC CORNEAS
 
 
 
 
 
 
 
10.4.4.1
INCREASING NUMBER OF CORNEAL BLINDNESS CASES GLOBALLY TO BOOST DEMAND FOR SYNTHETIC COLLAGEN BIOMATERIALS
 
 
 
 
 
10.4.5
OTHER OPHTHALMOLOGY APPLICATIONS
 
 
 
 
 
10.5
DENTAL
 
 
 
 
 
 
 
10.5.1
DENTAL IMPLANTS
 
 
 
 
 
 
 
10.5.1.1
RISING AWARENESS ABOUT DENTAL HEALTH AND INCREASING DENTAL PROCEDURES TO AUGMENT MARKET GROWTH
 
 
 
 
 
10.5.2
DENTAL BONE GRAFTS & SUBSTITUTES
 
 
 
 
 
 
 
10.5.2.1
GROWING DEMAND FOR DENTAL IMPLANTS DURING COSMETIC DENTISTRY TO DRIVE MARKET
 
 
 
 
 
10.5.3
DENTAL MEMBRANES
 
 
 
 
 
 
 
10.5.3.1
DENTAL MEMBRANES IN ORAL AND PERIODONTAL SURGERY TO PREVENT UNWANTED INFECTIONS IN ORAL CAVITY
 
 
 
 
 
10.5.4
TISSUE REGENERATION MATERIALS
 
 
 
 
 
 
 
10.5.4.1
INCREASING PREVALENCE OF PERIODONTAL DISEASE TO AUGMENT MARKET GROWTH
 
 
 
 
10.6
PLASTIC SURGERY
 
 
 
 
 
 
 
10.6.1
SOFT TISSUE FILLERS
 
 
 
 
 
 
 
10.6.1.1
LONG-LASTING CAPACITY AND FEWER ALLERGIC REACTIONS TO DRIVE DEMAND FOR SOFT-TISSUE FILLERS
 
 
 
 
 
10.6.2
CRANIOFACIAL SURGERY
 
 
 
 
 
 
 
10.6.2.1
INCREASING INCIDENCE OF TRAUMA CASES AND HEAD & NECK CANCER TO AUGMENT MARKET GROWTH
 
 
 
 
 
10.6.3
FACIAL WRINKLE TREATMENT
 
 
 
 
 
 
 
10.6.3.1
INCREASE IN DEMAND FOR NON-SURGICAL COSMETIC TREATMENTS TO PROPEL MARKET GROWTH
 
 
 
 
 
10.6.4
BIOENGINEERED SKINS
 
 
 
 
 
 
 
10.6.4.1
INCREASING INCIDENCE OF TRAUMA CASES AND HEAD & NECK CANCER TO INCREASE NUMBER OF CRANIOFACIAL SURGERIES
 
 
 
 
 
10.6.5
PERIPHERAL NERVE REPAIR
 
 
 
 
 
 
 
10.6.5.1
INCREASING INCIDENCE OF TRAUMA CASES TO RISE IN PERIPHERAL NERVE INJURIES
 
 
 
 
 
10.6.6
ACELLULAR DERMAL MATRICES
 
 
 
 
 
 
 
10.6.6.1
ABILITY TO PROVIDE SCAFFOLD FOR TISSUE REGENERATION AND REDUCE RISK OF IMMUNE REJECTION AND ADVERSE REACTIONS TO DRIVE SEGMENT
 
 
 
 
10.7
WOUND HEALING
 
 
 
 
 
 
 
10.7.1
WOUND CLOSURE DEVICES
 
 
 
 
 
 
 
10.7.1.1
SUTURES
 
 
 
 
 
 
 
 
10.7.1.1.1
SUTURES TO BE USED AS ADVANCED BIOLOGICALLY ACTIVE COMPONENTS FOR BETTER DRUG DELIVERY
 
 
 
 
10.7.1.2
STAPLES
 
 
 
 
 
 
 
 
10.7.1.2.1
EASE OF PLACEMENT AND ABILITY TO SHORTEN CLOSURE TO AUGMENT SEGMENT GROWTH
 
 
 
10.7.2
SURGICAL HEMOSTATS
 
 
 
 
 
 
 
10.7.2.1
SURGICAL HEMOSTATS TO CONTROL BLEEDING AND REDUCE FREQUENT BLOOD TRANSFUSIONS DURING SURGICAL PROCEDURES
 
 
 
 
 
10.7.3
INTERNAL TISSUE SEALANTS
 
 
 
 
 
 
 
10.7.3.1
INCREASING NUMBER OF SURGERIES TO DRIVE USE OF INTERNAL TISSUE SEALANTS
 
 
 
 
 
10.7.4
ADHESION BARRIERS
 
 
 
 
 
 
 
10.7.4.1
FOCUS ON INFLAMMATORY HEALING PROCESS TO DRIVE ADOPTION OF ADHESION BARRIERS IN SURGICAL PROCEDURES
 
 
 
 
 
10.7.5
HERNIA MESHES
 
 
 
 
 
 
 
10.7.5.1
POLYMERIC BIOMATERIAL-BASED MESHES TO BE USED IN HERNIA REPAIR
 
 
 
 
 
10.7.6
SKIN SUBSTITUTES
 
 
 
 
 
 
 
10.7.6.1
FOCUS ON PROMPTING TISSUE REGENERATION AND REPLACING DAMAGED SKIN WITH FUNCTIONAL TISSUE TO AID MARKET GROWTH
 
 
 
 
10.8
TISSUE ENGINEERING
 
 
 
 
 
 
 
10.8.1
SCAFFOLDS FOR BIOMATERIALS
 
 
 
 
 
 
 
10.8.1.1
RISE IN ORGAN TRANSPLANTATION PROCEDURES TO DRIVE MARKET
 
 
 
 
 
10.8.2
NANOMATERIALS FOR BIOSENSING
 
 
 
 
 
 
 
10.8.2.1
RISING RESEARCH IN NANOTECHNOLOGY TO AUGMENT MARKET GROWTH
 
 
 
 
 
10.8.3
TAILORING OF INORGANIC NANOPARTICLES
 
 
 
 
 
 
 
10.8.3.1
GROWING DEMAND FOR NANOTECHNOLOGICAL MEDICAL PRODUCTS TO DRIVE MARKET
 
 
 
 
10.9
NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
 
 
 
 
 
 
 
10.9.1
SHUNTING SYSTEMS
 
 
 
 
 
 
 
10.9.1.1
RISING CASES OF HYDROCEPHALUS TO BOOST MARKET GROWTH
 
 
 
 
 
10.9.2
CORTICAL NEURAL PROSTHETICS
 
 
 
 
 
 
 
10.9.2.1
INCREASED USE OF POLYMER-COATED CNPS TO TREAT PARALYZED PATIENTS
 
 
 
 
 
10.9.3
HYDROGEL SCAFFOLDS FOR CNS REPAIR
 
 
 
 
 
 
 
10.9.3.1
INCREASING INCIDENCE OF SPINAL CORD SURGERIES TO DRIVE DEMAND FOR HYDROGEL SCAFFOLDS
 
 
 
 
 
10.9.4
NEURAL STEM CELL ENCAPSULATION
 
 
 
 
 
 
 
10.9.4.1
LACK OF SUBSTITUTES FOR NEUROTRAUMA TREATMENT TO BOOST MARKET GROWTH
 
 
 
 
10.10
URINARY
 
 
 
 
 
 
 
10.10.1
URINARY CATHETERS
 
 
 
 
 
 
 
10.10.1.1
RISE IN IMPLANT-RELATED CASES OF BIOFILM-ASSOCIATED INFECTIONS TO HINDER MARKET GROWTH
 
 
 
 
 
10.10.2
URETHRAL STENTS
 
 
 
 
 
 
10.10.3
OTHER URINARY APPLICATIONS
 
 
 
 
 
10.11
OTHER APPLICATIONS
 
 
 
 
 
 
 
10.11.1
DRUG DELIVERY SYSTEMS
 
 
 
 
 
 
10.11.2
GASTROINTESTINAL APPLICATIONS
 
 
 
 
 
 
10.11.3
BARIATRIC SURGERY
 
 
 
 
11
BIOMATERIALS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 4 Data Tables
 
 
 
 
 
230
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
MEDICAL DEVICE MANUFACTURERS
 
 
 
 
 
 
 
11.2.1
DEMOGRAPHIC SHIFTS, TECHNOLOGICAL INNOVATION, AND EXPANDING CLINICAL APPLICATIONS TO DRIVE MARKET
 
 
 
 
 
11.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
11.3.1
INVESTMENT AND INNOVATION MOMENTUM IN PHARMA & BIOTECH TO ACCELERATE GLOBAL BIOMATERIAL ADOPTION
 
 
 
 
 
11.4
OTHER END USERS
 
 
 
 
 
12
BIOMATERIALS MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 17 Countries | 674 Data Tables.
 
 
 
 
 
235
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
NORTH AMERICA
 
 
 
 
 
 
 
12.2.1
US
 
 
 
 
 
 
 
12.2.1.1
RISING INCIDENCE OF CANCER AND ONGOING RESEARCH IN DEVELOPING BIOCOMPATIBLE MATERIALS TO DRIVE MARKET
 
 
 
 
 
12.2.2
CANADA
 
 
 
 
 
 
 
12.2.2.1
GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET GROWTH
 
 
 
 
12.3
EUROPE
 
 
 
 
 
 
 
12.3.1
GERMANY
 
 
 
 
 
 
 
12.3.1.1
RISING FOCUS ON CLINICAL RESEARCH AND INCREASING NUMBER OF PATENT APPROVALS TO AID MARKET GROWTH
 
 
 
 
 
12.3.2
UK
 
 
 
 
 
 
 
12.3.2.1
INCREASING RESEARCH ACTIVITIES AND RISING NUMBER OF CARDIOVASCULAR PROCEDURES TO SUPPORT MARKET GROWTH
 
 
 
 
 
12.3.3
FRANCE
 
 
 
 
 
 
 
12.3.3.1
INCREASED HEALTHCARE EXPENDITURE AND STRUCTURED REGULATORY FRAMEWORK TO AUGMENT MARKET GROWTH
 
 
 
 
 
12.3.4
ITALY
 
 
 
 
 
 
 
12.3.4.1
RISING PREVALENCE OF NEUROLOGICAL AND CARDIOVASCULAR DISORDERS TO BOOST MARKET GROWTH
 
 
 
 
 
12.3.5
SPAIN
 
 
 
 
 
 
 
12.3.5.1
INCREASED FOCUS ON RESEARCH FOR BIOMATERIAL DEVELOPMENT TO PROPEL MARKET GROWTH
 
 
 
 
 
12.3.6
REST OF EUROPE
 
 
 
 
 
12.4
ASIA PACIFIC
 
 
 
 
 
 
 
12.4.1
CHINA
 
 
 
 
 
 
 
12.4.1.1
LUCRATIVE MEDICAL DEVICES INDUSTRY AND LARGE GERIATRIC POPULATION TO DRIVE MARKET
 
 
 
 
 
12.4.2
JAPAN
 
 
 
 
 
 
 
12.4.2.1
GROWING MEDICAL DEVICES INDUSTRY AND RISING FOCUS ON MEDICAL RESEARCH TO SUPPORT MARKET GROWTH
 
 
 
 
 
12.4.3
INDIA
 
 
 
 
 
 
 
12.4.3.1
LARGE POPULATION BASE AND HIGH FOCUS ON MEDICAL TOURISM TO AID MARKET GROWTH
 
 
 
 
 
12.4.4
SOUTH KOREA
 
 
 
 
 
 
 
12.4.4.1
HIGH DEMAND FOR HEALTHCARE SERVICES AND ADVANCED TREATMENTS TO SPUR MARKET GROWTH
 
 
 
 
 
12.4.5
AUSTRALIA
 
 
 
 
 
 
 
12.4.5.1
STRATEGIC PUBLIC AND SECTOR-WIDE INVESTMENTS WITH CLINICAL TRIAL SYSTEM REFORM TO UNDERPIN BIOMEDICAL RESEARCH GROWTH
 
 
 
 
 
12.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
12.5
LATIN AMERICA
 
 
 
 
 
 
 
12.5.1
BRAZIL
 
 
 
 
 
 
 
12.5.1.1
GRADUAL INCREASE IN PHARMACEUTICAL R&D TO FUEL MARKET GROWTH
 
 
 
 
 
12.5.2
MEXICO
 
 
 
 
 
 
 
12.5.2.1
RISING NUMBER OF COSMETIC PROCEDURES TO BOOST ADOPTION OF BIOMATERIALS
 
 
 
 
 
12.5.3
ARGENTINA
 
 
 
 
 
 
 
12.5.3.1
INCREASED INCIDENCE OF CARDIOVASCULAR DISEASES AND FAVORABLE GOVERNMENT HEALTHCARE SYSTEM TO AID MARKET GROWTH
 
 
 
 
 
12.5.4
REST OF LATIN AMERICA
 
 
 
 
 
12.6
MIDDLE EAST
 
 
 
 
 
 
 
12.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
12.6.1.1
KINGDOM OF SAUDI ARABIA
 
 
 
 
 
 
 
 
12.6.1.1.1
INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
 
 
 
 
12.6.1.2
UAE
 
 
 
 
 
 
 
 
12.6.1.2.1
STRATEGIC PARTNERSHIPS AND REGULATORY ALIGNMENT TO DRIVE GLOBAL BIOMATERIALS MARKET GROWTH
 
 
 
 
12.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
 
12.6.2
REST OF MIDDLE EAST
 
 
 
 
 
12.7
AFRICA
 
 
 
 
 
 
 
12.7.1
EXPANSION IN HEALTHCARE INDUSTRY AND SUPPORTIVE REGULATORY POLICIES TO AID MARKET GROWTH
 
 
 
 
13
COMPETITIVE LANDSCAPE
Uncover strategic shifts and revenue trends shaping biomaterials market leaders and emerging competitors.
 
 
 
 
 
518
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
KEY STRATEGIES ADOPTED BY MAJOR PLAYERS
 
 
 
 
 
 
 
13.2.1
STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET
 
 
 
 
 
13.3
REVENUE ANALYSIS, 2023–2025
 
 
 
 
 
 
 
13.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
 
 
 
 
 
 
 
 
13.5.1
STARS
 
 
 
 
 
 
13.5.2
EMERGING LEADERS
 
 
 
 
 
 
13.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
13.5.4
PARTICIPANTS
 
 
 
 
 
 
13.5.5
COMPETITIVE BENCHMARKING: KEY PLAYERS, 2025
 
 
 
 
 
 
 
13.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
13.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
13.5.5.3
TYPE FOOTPRINT
 
 
 
 
 
 
13.5.5.4
APPLICATION FOOTPRINT
 
 
 
 
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES
 
 
 
 
 
 
 
 
13.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
13.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
13.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
13.6.4
STARTING BLOCKS
 
 
 
 
 
 
13.6.5
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
 
 
 
13.6.5.1
LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
13.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
13.7.1
FINANCIAL METRICS
 
 
 
 
 
 
13.7.2
COMPANY VALUATION
 
 
 
 
 
13.8
BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
 
13.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
13.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
13.9.2
DEALS
 
 
 
 
 
 
13.9.3
EXPANSIONS
 
 
 
 
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
536
 
14.1
KEY PLAYERS
 
 
 
 
 
 
 
14.1.1
BASF SE
 
 
 
 
 
 
 
14.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
14.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
14.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
14.1.1.3.1
DEALS
 
 
 
 
 
 
14.1.1.3.2
OTHER DEVELOPMENTS
 
 
 
 
14.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
14.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
14.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
14.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
14.1.2
COVESTRO AG
 
 
 
 
 
 
14.1.3
CELANESE CORPORATION
 
 
 
 
 
 
14.1.4
CARPENTER TECHNOLOGY CORPORATION
 
 
 
 
 
 
14.1.5
EVONIK INDUSTRIES AG
 
 
 
 
 
 
14.1.6
DSM
 
 
 
 
 
 
14.1.7
CORBION NV
 
 
 
 
 
 
14.1.8
VICTREX PLC
 
 
 
 
 
 
14.1.9
MITSUBISHI CHEMICAL CORPORATION
 
 
 
 
 
 
14.1.10
COORSTEK INC.
 
 
 
 
 
 
14.1.11
BERKELEY ADVANCED BIOMATERIALS
 
 
 
 
 
 
14.1.12
CAM BIOCERAMICS B.V.
 
 
 
 
 
 
14.1.13
ZEUS COMPANY INC.
 
 
 
 
 
 
14.1.14
AMETEK INC.
 
 
 
 
 
 
14.1.15
GELITA AG
 
 
 
 
 
14.2
OTHER PLAYERS
 
 
 
 
 
 
 
14.2.1
COLLAGEN SOLUTIONS (US) LLC)
 
 
 
 
 
 
14.2.2
BIOCOMPOSITES
 
 
 
 
 
 
14.2.3
NOBLE BIOMATERIALS, INC.
 
 
 
 
 
 
14.2.4
REGENITY
 
 
 
 
 
 
14.2.5
KURARAY CO., LTD.
 
 
 
 
 
 
14.2.6
SOLESIS
 
 
 
 
 
 
14.2.7
INSTITUT STRAUMANN AG
 
 
 
 
 
 
14.2.8
FOSTER CORPORATION
 
 
 
 
 
 
14.2.9
CDI PRODUCTS
 
 
 
 
 
 
14.2.10
REVBIO, INC.
 
 
 
 
15
RESEARCH METHODOLOGY
 
 
 
 
 
598
 
15.1
RESEARCH DATA
 
 
 
 
 
 
 
15.1.1
SECONDARY DATA
 
 
 
 
 
 
 
15.1.1.1
KEY OBJECTIVES OF SECONDARY RESEARCH
 
 
 
 
 
15.1.2
PRIMARY DATA
 
 
 
 
 
 
 
15.1.2.1
BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
15.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
 
 
 
 
15.2
MARKET ESTIMATION METHODOLOGY
 
 
 
 
 
 
15.3
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
15.3.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
 
 
 
 
 
 
15.3.2
MNM REPOSITORY ANALYSIS
 
 
 
 
 
 
15.3.3
PRIMARY INTERVIEWS
 
 
 
 
 
 
15.3.4
INSIGHTS OF PRIMARY EXPERTS
 
 
 
 
 
 
15.3.5
TOP-DOWN APPROACH
 
 
 
 
 
15.4
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
 
15.5
DATA TRIANGULATION
 
 
 
 
 
 
15.6
STUDY ASSUMPTIONS
 
 
 
 
 
 
15.7
RESEARCH LIMITATIONS
 
 
 
 
 
 
15.8
RISK ANALYSIS
 
 
 
 
 
16
APPENDIX
 
 
 
 
 
610
 
16.1
DISCUSSION GUIDE
 
 
 
 
 
 
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
16.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
16.4
RELATED REPORTS
 
 
 
 
 
 
16.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
BIOMATERIALS MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
IMPACT ANALYSIS OF FACTORS IN BIOMATERIALS MARKET
 
 
 
 
 
 
TABLE 3
IMPACT OF PORTER’S FIVE FORCES ON BIOMATERIALS MARKET
 
 
 
 
 
 
TABLE 4
ROLE OF KEY COMPANIES (DEMAND/SUPPLY SIDES) IN BIOMATERIALS MARKET ECOSYSTEM
 
 
 
 
 
 
TABLE 5
INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
TABLE 6
INDICATIVE SELLING PRICE OF BIOMATERIALS, BY REGION, 2025 (USD)
 
 
 
 
 
 
TABLE 7
IMPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 8
EXPORT DATA FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 9
IMPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 10
EXPORT VOLUME FOR HS CODE 7221 (STAINLESS STEEL), BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 11
IMPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 12
EXPORT DATA FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 13
IMPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 14
EXPORT VOLUME FOR HS CODE 284329 (SILVER), BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 15
IMPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 16
EXPORT DATA FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 17
IMPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 18
EXPORT VOLUME FOR HS CODE 281820 (ALUMINUM OXIDE), BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 19
IMPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 20
EXPORT DATA FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 21
IMPORT VOLUME FOR HS CODE 3910 (SILICONE), BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 22
EXPORT VOLUME FOR HS CODE 3910, BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 23
KEY CONFERENCES & EVENTS IN BIOMATERIALS MARKET, JANUARY 2026–DECEMBER 2027
 
 
 
 
 
 
TABLE 24
CASE STUDY 1: SCALING MEDICAL-GRADE POLYMER SUPPLY THROUGH INTEGRATED VERBUND MANUFACTURING
 
 
 
 
 
 
TABLE 25
CASE STUDY 2: STRENGTHENING HIGH-PERFORMANCE POLYMER PLATFORMS FOR REGULATED BIOMATERIALS APPLICATIONS
 
 
 
 
 
 
TABLE 26
CASE STUDY 3: ADVANCING BIORESORBABLE AND BIOCOMPATIBLE MATERIALS FOR CLINICAL AND COMMERCIAL SCALE-UP
 
 
 
 
 
 
TABLE 27
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 28
INDICATIVE LIST OF PATENTS IN BIOMATERIALS MARKET, 2025
 
 
 
 
 
 
TABLE 29
CASE STUDIES OF AI IMPLEMENTATION IN BIOMATERIALS MARKET
 
 
 
 
 
 
TABLE 30
CLIENT’S READINESS TO ADOPT GENERATIVE AI IN BIOMATERIALS MARKET
 
 
 
 
 
 
TABLE 31
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 32
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 33
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 34
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 35
COUNTRY-WISE REGULATORY SCENARIO FOR BIOMATERIAL MANUFACTURERS
 
 
 
 
 
 
TABLE 36
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
 
 
 
 
 
 
TABLE 37
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
TABLE 38
IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
 
 
 
 
 
 
TABLE 39
BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
STAINLESS STEEL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
SILVER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
GOLD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
MAGNESIUM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
APPLICATIONS OF SYNTHETIC POLYMERS
 
 
 
 
 
 
TABLE 50
POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
POLYMETHYLMETHACRYLATE (PMMA) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
POLYETHYLENE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
POLYESTER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
SILICONE RUBBER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
NYLON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
POLYETHERETHERKETONE (PEEK) BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
CERAMIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
CARBON BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
GLASS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
APPLICATIONS OF NATURAL BIOMATERIALS
 
 
 
 
 
 
TABLE 69
NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
HYALURONIC ACID BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
COLLAGEN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
FIBRIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
CELLULOSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
CHITIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
ALGINATES BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
GELATIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
CHITOSAN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
SILK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
BIORESORBABLE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
BIORESORBABLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
SUTURE ANCHOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
INTERFERENCE SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
MENISCAL REPAIR TACK BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
SPINAL FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
MINIMALLY INVASIVE FUSION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
MOTION PRESERVATION & DYNAMIC STABILIZATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
PEDICLE-BASED ROD SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
INTERSPINOUS SPACER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
ARTIFICIAL DISC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
BIOMATERIALS MARKET FOR FRACTURE FIXATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
FRACTURE FIXATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
BONE PLATE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
SCREW BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
PIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
ROD BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
WIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
ORTHOBIOLOGICS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
IMPLANTABLE CARDIAC DEFIBRILLATOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
PACEMAKER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
SENSOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
 
 
 
 
 
 
TABLE 121
HEART VALVE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
VASCULAR GRAFT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
GUIDEWIRE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
OTHER CARDIOVASCULAR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
CONTACT LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
INTRAOCULAR LENSE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
FUNCTIONAL REPLACEMENTS OF OCULAR TISSUE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
SYNTHETIC CORNEA BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
OTHER OPHTHALMOLOGY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
DENTAL IMPLANT BIOMAERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
DENTAL BONE GRAFT & SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
DENTAL MEMBRANE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
TISSUE REGENERATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
SOFT TISSUE FILLERS BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
CRANIOFACIAL SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
FACIAL WRINKLE TREATMENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
BIOENGINEERED SKIN BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
PERIPHERAL NERVE REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
ACELLULAR DERMAL MATRICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
SUTURE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
STAPLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
SURGICAL HEMOSTAT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
INTERNAL TISSUE SEALANT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
ADHESION BARRIER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
HERNIA MESH BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
SKIN SUBSTITUTE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
SCAFFOLDS FOR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
NANOMATERIALS FOR BIOSENSING BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
TAILORING OF INORGANIC NANOPARTICLE BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS,BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
SHUNTING SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
CORTICAL NEURAL PROSTHETIC BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
HYDROGEL SCAFFOLD FOR CNS REPAIR BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
NEURAL STEM CELL ENCAPSULATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
URINARY CATHETER BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
URETHRAL STENT BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
OTHER URINARY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
DRUG DELIVERY SYSTEM BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
GASTROINTESTINAL APPLICATION BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
BARIATRIC SURGERY BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
BIOMATERIALS MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 180
BIOMATERIALS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
BIOMATERIALS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
NORTH AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
NORTH AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
NORTH AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
NORTH AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
NORTH AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
NORTH AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
NORTH AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
NORTH AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
NORTH AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
NORTH AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
NORTH AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
NORTH AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
NORTH AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
NORTH AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
NORTH AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
NORTH AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
US: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
US: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
US: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
US: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
US: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
US: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
US: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
US: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
US: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
US: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
US: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
US: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
US: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
US: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
US: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
US: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
US: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
US: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
CANADA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
CANADA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
CANADA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
CANADA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
CANADA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
CANADA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
CANADA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
CANADA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
CANADA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
CANADA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
CANADA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
CANADA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
CANADA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
CANADA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
CANADA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
CANADA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
CANADA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
EUROPE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
GERMANY: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
GERMANY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
GERMANY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
GERMANY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
GERMANY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
GERMANY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
GERMANY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
GERMANY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
GERMANY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
GERMANY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
GERMANY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
GERMANY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
GERMANY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
GERMANY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
GERMANY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
GERMANY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
GERMANY: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
UK: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
UK: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
UK: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
UK: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
UK: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
UK: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
UK: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
UK: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
UK: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
UK: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
UK: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
UK: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
UK: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
UK: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
UK: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
UK: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
UK: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
UK: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
UK: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
FRANCE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
FRANCE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
FRANCE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
FRANCE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
FRANCE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
FRANCE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
FRANCE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
FRANCE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
FRANCE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
FRANCE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
FRANCE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
FRANCE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
FRANCE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
FRANCE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
FRANCE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
FRANCE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
FRANCE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
FRANCE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
FRANCE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
FRANCE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
FRANCE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
FRANCE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
ITALY: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
ITALY: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
ITALY: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
ITALY: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
ITALY: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
ITALY: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
ITALY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
ITALY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
ITALY: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
ITALY: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
ITALY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
ITALY: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
ITALY: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
ITALY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
ITALY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
ITALY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
ITALY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
ITALY: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
ITALY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
ITALY: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
ITALY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
ITALY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
ITALY: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
SPAIN: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
SPAIN: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
SPAIN: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
SPAIN: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
SPAIN: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
SPAIN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
SPAIN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
SPAIN: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
SPAIN: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
SPAIN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
SPAIN: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
SPAIN: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
SPAIN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
SPAIN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
SPAIN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
SPAIN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
SPAIN: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
SPAIN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
SPAIN: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
SPAIN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
SPAIN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
SPAIN: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
REST OF EUROPE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
REST OF EUROPE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
REST OF EUROPE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
REST OF EUROPE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
REST OF EUROPE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
REST OF EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
REST OF EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
REST OF EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
REST OF EUROPE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
REST OF EUROPE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
REST OF EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
REST OF EUROPE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
REST OF EUROPE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
REST OF EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
REST OF EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
REST OF EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
REST OF EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
REST OF EUROPE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
REST OF EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
REST OF EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
REST OF EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
REST OF EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
REST OF EUROPE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
ASIA PACIFIC: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
ASIA PACIFIC: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
ASIA PACIFIC: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
ASIA PACIFIC: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
ASIA PACIFIC: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
ASIA PACIFIC: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
ASIA PACIFIC: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
ASIA PACIFIC: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
ASIA PACIFIC: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
ASIA PACIFIC: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
ASIA PACIFIC: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
CHINA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
CHINA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
CHINA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
CHINA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
CHINA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
CHINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
CHINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
CHINA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
CHINA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
CHINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
CHINA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
CHINA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
CHINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
CHINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
CHINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
CHINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
CHINA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
CHINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
CHINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
CHINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
CHINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
CHINA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
JAPAN: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
JAPAN: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
JAPAN: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
JAPAN: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
JAPAN: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
JAPAN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
JAPAN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
JAPAN: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
JAPAN: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
JAPAN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
JAPAN: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
JAPAN: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
JAPAN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
JAPAN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
JAPAN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
JAPAN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
JAPAN: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
JAPAN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
JAPAN: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
JAPAN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
JAPAN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
JAPAN: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
INDIA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
INDIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
INDIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
INDIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
INDIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
INDIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
INDIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
INDIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
INDIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
INDIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
INDIA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
INDIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
INDIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
INDIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
INDIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
INDIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
INDIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
INDIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
INDIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
INDIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
INDIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
INDIA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
SOUTH KOREA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
SOUTH KOREA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
SOUTH KOREA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
SOUTH KOREA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
SOUTH KOREA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
SOUTH KOREA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
SOUTH KOREA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
SOUTH KOREA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
SOUTH KOREA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
SOUTH KOREA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
SOUTH KOREA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
SOUTH KOREA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
SOUTH KOREA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
SOUTH KOREA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
SOUTH KOREA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
SOUTH KOREA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
SOUTH KOREA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
SOUTH KOREA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
SOUTH KOREA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
SOUTH KOREA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
SOUTH KOREA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
SOUTH KOREA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
SOUTH KOREA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
AUSTRALIA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
AUSTRALIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
AUSTRALIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
AUSTRALIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
AUSTRALIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
AUSTRALIA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
AUSTRALIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
AUSTRALIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
AUSTRALIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
AUSTRALIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
AUSTRALIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
AUSTRALIA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
AUSTRALIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
AUSTRALIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
AUSTRALIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
AUSTRALIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
AUSTRALIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 548
AUSTRALIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
AUSTRALIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 550
AUSTRALIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
AUSTRALIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 552
AUSTRALIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
AUSTRALIA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 554
REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 555
REST OF ASIA PACIFIC: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 556
REST OF ASIA PACIFIC: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
REST OF ASIA PACIFIC: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 558
REST OF ASIA PACIFIC: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 560
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 562
REST OF ASIA PACIFIC: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
REST OF ASIA PACIFIC: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 564
REST OF ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
REST OF ASIA PACIFIC : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 566
REST OF ASIA PACIFIC: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 568
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 569
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 570
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 571
REST OF ASIA PACIFIC: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 572
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 573
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 574
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 575
REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 576
REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 577
LATIN AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 578
LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 579
LATIN AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 580
LATIN AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 581
LATIN AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 582
LATIN AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 583
LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 584
LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 585
LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 586
LATIN AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 587
LATIN AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 588
LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 589
LATIN AMERICA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 590
LATIN AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 591
LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 592
LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 593
LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 594
LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 595
LATIN AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 596
LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 597
LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 598
LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 599
LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 600
LATIN AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 601
BRAZIL: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 602
BRAZIL: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 603
BRAZIL: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 604
BRAZIL: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 605
BRAZIL: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 606
BRAZIL: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 607
BRAZIL: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 608
BRAZIL: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 609
BRAZIL: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 610
BRAZIL: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 611
BRAZIL: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 612
BRAZIL: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 613
BRAZIL: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 614
BRAZIL: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 615
BRAZIL: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 616
BRAZIL: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 617
BRAZIL: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 618
BRAZIL: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 619
BRAZIL: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 620
BRAZIL: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 621
BRAZIL: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 622
BRAZIL: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 623
BRAZIL: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 624
MEXICO: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 625
MEXICO: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 626
MEXICO: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 627
MEXICO: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 628
MEXICO: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 629
MEXICO: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 630
MEXICO: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 631
MEXICO: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 632
MEXICO: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 633
MEXICO: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 634
MEXICO: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 635
MEXICO: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 636
MEXICO: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 637
MEXICO: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 638
MEXICO: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 639
MEXICO: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 640
MEXICO: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 641
MEXICO: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 642
MEXICO: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 643
MEXICO: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 644
MEXICO: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 645
MEXICO: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 646
MEXICO: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 647
ARGENTINA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 648
ARGENTINA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 649
ARGENTINA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 650
ARGENTINA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 651
ARGENTINA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 652
ARGENTINA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 653
ARGENTINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 654
ARGENTINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 655
ARGENTINA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 656
ARGENTINA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 657
ARGENTINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 658
ARGENTINA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 659
ARGENTINA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 660
ARGENTINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 661
ARGENTINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 662
ARGENTINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 663
ARGENTINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 664
ARGENTINA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 665
ARGENTINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 666
ARGENTINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 667
ARGENTINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 668
ARGENTINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 669
ARGENTINA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 670
REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 671
REST OF LATIN AMERICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 672
REST OF LATIN AMERICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 673
REST OF LATIN AMERICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 674
REST OF LATIN AMERICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 675
REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 676
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 677
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 678
REST OF LATIN AMERICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 679
REST OF LATIN AMERICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 680
REST OF LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 681
REST OF LATIN AMERICA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 682
REST OF LATIN AMERICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 683
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 684
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 685
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 686
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 687
REST OF LATIN AMERICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 688
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 689
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 690
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 691
REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 692
REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 693
MIDDLE EAST: BIOMATERIALS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 694
MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 695
MIDDLE EAST: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 696
MIDDLE EAST: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 697
MIDDLE EAST: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 698
MIDDLE EAST: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 699
MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 700
MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 701
MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 702
MIDDLE EAST: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 703
MIDDLE EAST: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 704
MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 705
MIDDLE EAST: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 706
MIDDLE EAST: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 707
MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 708
MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 709
MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 710
MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 711
MIDDLE EAST: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 712
MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 713
MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 714
MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 715
MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 716
MIDDLE EAST: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 717
GCC COUNTRIES: BIOMATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 718
GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 719
GCC COUNTRIES: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 720
GCC COUNTRIES: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 721
GCC COUNTRIES: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 722
GCC COUNTRIES: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 723
GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 724
GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 725
GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 726
GCC COUNTRIES: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 727
GCC COUNTRIES: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 728
GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 729
GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 730
GCC COUNTRIES: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 731
GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 732
GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 733
GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 734
GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 735
GCC COUNTRIES: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 736
GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 737
GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 738
GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 739
GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 740
GCC COUNTRIES: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 741
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 742
KINGDOM OF SAUDI ARABIA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 743
KINGDOM OF SAUDI ARABIA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 744
KINGDOM OF SAUDI ARABIA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 745
KINGDOM OF SAUDI ARABIA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 746
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 747
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 748
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 749
KINGDOM OF SAUDI ARABIA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 750
KINGDOM OF SAUDI ARABIA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 751
KINGDOM OF SAUDI ARABIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 752
KINGDOM OF SAUDI ARABIA: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 753
KINGDOM OF SAUDI ARABIA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 754
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 755
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 756
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 757
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 758
KINGDOM OF SAUDI ARABIA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 759
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 760
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 761
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 762
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 763
KINGDOM OF SAUDI ARABIA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 764
UAE: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 765
UAE: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 766
UAE: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 767
UAE: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 768
UAE: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 769
UAE: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 770
UAE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 771
UAE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 772
UAE: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 773
UAE: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 774
UAE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 775
UAE: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 776
UAE: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 777
UAE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 778
UAE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 779
UAE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 780
UAE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 781
UAE: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 782
UAE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 783
UAE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 784
UAE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 785
UAE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 786
UAE: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 787
REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 788
REST OF GCC COUNTRIES: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 789
REST OF GCC COUNTRIES: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 790
REST OF GCC COUNTRIES: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 791
REST OF GCC COUNTRIES: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 792
REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 793
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 794
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 795
REST OF GCC COUNTRIES: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 796
REST OF GCC COUNTRIES: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 797
REST OF GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 798
REST OF GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 799
REST OF GCC COUNTRIES: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 800
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 801
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 802
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 803
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 804
REST OF GCC COUNTRIES: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 805
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 806
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 807
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 808
REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 809
REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 810
REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 811
REST OF MIDDLE EAST: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 812
REST OF MIDDLE EAST: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 813
REST OF MIDDLE EAST: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 814
REST OF MIDDLE EAST: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 815
REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 816
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 817
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 818
REST OF MIDDLE EAST: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 819
REST OF MIDDLE EAST: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 820
REST OF MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 821
REST OF MIDDLE EAST: BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 822
REST OF MIDDLE EAST: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 823
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 824
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 825
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 826
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 827
REST OF MIDDLE EAST: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 828
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 829
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 830
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 831
REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 832
REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 833
AFRICA: BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 834
AFRICA: METALLIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 835
AFRICA: CERAMIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 836
AFRICA: POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 837
AFRICA: NATURAL BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 838
AFRICA: BIOMATERIALS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 839
AFRICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 840
AFRICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 841
AFRICA: JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 842
AFRICA: SPINE SURGERY BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 843
AFRICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 844
AFRICA : BIORESORBABLE TISSUE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 845
AFRICA: FRACTURE FIXATION BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 846
AFRICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 847
AFRICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 848
AFRICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 849
AFRICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 850
AFRICA: WOUND CLOSURE DEVICE BIOMATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 851
AFRICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 852
AFRICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 853
AFRICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 854
AFRICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 855
AFRICA: BIOMATERIALS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 856
STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, JANAURY 2023−FEBRUARY 2026
 
 
 
 
 
 
TABLE 857
BIOMATERIALS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 858
BIOMATERIALS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 859
BIOMATERIALS MARKET: TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 860
BIOMATERIALS MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 861
LIST OF KEY STARTUPS/SME PLAYERS IN BIOMATERIALS MARKET
 
 
 
 
 
 
TABLE 862
BIOMATERIALS: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION
 
 
 
 
 
 
TABLE 863
BIOMATERIALS MARKET: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 864
BIOMATERIALS MARKET: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 865
BIOMATERIALS MARKET: EXPANSIONS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 866
BASF SE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 867
BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 868
BASF SE: DEALS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 869
BASF SE: OTHER DEVELOPMENTS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 870
COVESTRO AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 871
COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 872
COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 873
COVESTRO AG: DEALS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 874
COVESTRO AG: EXPANSIONS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 875
COVESTRO AG: OTHER DEVELOPMENTS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 876
CELANESE CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 877
CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 878
CELANESE CORPORATION: DEALS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 879
CARPENTER TECHNOLOGY CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 880
CARPENTER TECHNOLOGY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 881
CARPPENTER TECHNOLOGY CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 882
EVONIK INDUSTRIES AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 883
EVONIK INDUSTRIES AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 884
EVONIK INDUSTRIES AG: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 885
EVONIK INDUSTRIES AG: DEALS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 886
DSM: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 887
DSM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 888
DSM: DEALS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 889
DSM: EXPANSIONS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 890
CORBION NV: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 891
CORBION NV: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 892
CORBION NV: EXPANSIONS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 893
VICTREX PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 894
VICTREX PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 895
VICTREX PLC: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 896
VICTREX PLC: EXPANSIONS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 897
MITSUBISHI CHEMICAL CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 898
MITSUBISHI CHEMICAL CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 899
COORSTEK INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 900
COORSTEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 901
BERKELEY ADVANCED BIOMATERIALS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 902
BERKELEY ADVANCED BIOMATERIALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 903
CAM BIOCERAMICS B.V.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 904
CAM BIOCERAMICS B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 905
CAM BIOCERAMICS B.V.: DEALS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 906
ZEUS COMPANY INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 907
ZEUS COMPANY INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 908
ZEUS COMPANY INC.: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 909
ZEUS COMPANY INC.: EXPANSIONS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 910
AMETEK.INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 911
AMETEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 912
AMETEK INC.: DEALS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 913
AMETEK.INC.: EXPANSIONS, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 914
GELITA AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 915
GELITA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 916
GELITA AG.: PRODUCT LAUNCHES, JANUARY 2023–FEBRUARY 2026
 
 
 
 
 
 
TABLE 917
COLLAGEN SOLUTIONS (US) LLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 918
BIOCOMPOSITES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 919
NOBLE BIOMATERIALS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 920
REGENITY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 921
KURARAY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 922
SOLESIS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 923
INSTITUT STRAUMANN AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 924
FOSTER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 925
CDI PRODUCTS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 926
REVBIO, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 927
IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN BIOMATERIALS MARKET
 
 
 
 
 
 
TABLE 928
BIOMATERIALS MARKET: RISK ANALYSIS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
BIOMATERIALS MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
BIOMATERIALS MARKET: REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 3
BIOMATERIALS MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 4
BIOMATERIALS MARKET SCENARIO
 
 
 
 
 
 
FIGURE 5
GLOBAL BIOMATERIALS MARKET SIZE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 6
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 7
DISRUPTIONS INFLUENCING BIOMATERIALS MARKET GROWTH
 
 
 
 
 
 
FIGURE 8
HIGH-GROWTH SEGMENTS IN BIOMATERIALS MARKET, BY TYPE, APPLICATION, END USER, AND REGION (2026–2031)
 
 
 
 
 
 
FIGURE 9
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN BIOMATERIALS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
RISING ADVANCEMENTS IN SMART, BIOCOMPATIBLE, AND 3D PRINTED BIOMATERIALS TO DRIVE MARKET
 
 
 
 
 
 
FIGURE 11
US AND METALLIC BIOMATERIALS ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
 
 
 
 
 
 
FIGURE 12
CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
 
 
 
 
 
 
FIGURE 13
BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 14
BIOMATERIALS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 15
BIOMATERIALS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 16
BIOMATERIALS MARKET ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 17
INDICATIVE SELLING PRICE OF BIOMATERIALS, BY KEY PLAYER, 2025 (USD)
 
 
 
 
 
 
FIGURE 18
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN BIOMATERIALS MARKET
 
 
 
 
 
 
 
FUNDING AND NUMBER OF DEALS IN BIOMATERIALS MARKET,
 
 
 
 
 
 
2025
(USD MILLION)
 
 
 
 
 
105
FIGURE 20
TOP APPLICANTS/OWNERS (COMPANIES) FOR BIOMATERIAL PATENTS, 2015–2025
 
 
 
 
 
 
FIGURE 21
IMPACT OF AI/GEN AI ON BIOMATERIALS MARKET
 
 
 
 
 
 
FIGURE 22
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
 
 
 
 
 
 
FIGURE 23
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
FIGURE 24
NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 25
ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 26
REVENUE ANALYSIS OF KEY PLAYERS IN BIOMATERIALS MARKET, 2023–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 27
BIOMATERIALS MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
 
 
 
 
 
 
FIGURE 28
BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 29
BIOMATERIALS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 30
BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 31
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 32
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 33
BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TYPE, IN BIOMATERIALS MARKET
 
 
 
 
 
 
FIGURE 34
BASF SE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 35
COVESTRO AG: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 36
CELANESE CORPORATION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 37
CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 38
EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 39
DSM: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 40
CORBION NV: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 41
VICTREX PLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 42
MITSUBISHI CHEMICAL CORPORATION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 43
AMETEK.INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 44
BIOMATERIALS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 45
BIOMATERIALS MARKET: BREAKDOWN OF DEMAND- AND SUPPLY-SIDE PRIMARIES
 
 
 
 
 
 
FIGURE 46
BIOMATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
 
 
 
 
 
 
FIGURE 47
BIOMATERIALS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2025
 
 
 
 
 
 
FIGURE 48
REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF COVESTRO AG (2025)
 
 
 
 
 
 
FIGURE 49
BIOMATERIALS MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 50
BIOMATERIALS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 51
BIOMATERIALS MARKET: CAGR PROJECTIONS
 
 
 
 
 
 
FIGURE 52
DATA TRIANGULATION METHODOLOGY IN BIOMATERIALS MARKET
 
 
 
 
 
 

Methodology

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyse the global Biomaterials market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Global Biomaterials market. The secondary sources used for this study includes US Food and Drug Administration (USFDA), European Medicines Agency (EMA), National Institutes of Health (NIH), National Institute of Standards and Technology (NIST), European Commission (EC), Centers for Disease Control and Prevention (CDC), National Science Foundation (NSF), World Health Organization (WHO), Journal of Biomedical Nanotechnology, Journal of Materials Science, Materials Science and Engineering, Journal of Biomedical Materials Research, Biomedical Engineering Society (BMES), American Society for Testing and Materials (ASTM) International, Society for Biomaterials (SFB), European Society for Biomaterials (ESB); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Following an initial assessment of the global biomaterials market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to understand the market dynamics comprehensively.

The following is a breakdown of the primary respondents:

Biomaterials Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both bottom-up and top-down approaches were used to estimate and validate the total size of the Global Biomaterials market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • A list of the major global players operating in the Biomaterials market was generated.
  • The revenues generated from their Biomaterials product have been determined through annual reports and secondary sources (including paid databases)
  • The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.
  • All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

Biomaterials Market : Top-Down and Bottom-Up Approach

Biomaterials Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Biomaterials refer to substances that have been engineered to interact with biological systems for medical purposes. These materials are designed to be compatible with living tissues and can be used in various medical applications, such as implants, prosthetics, drug delivery systems, and tissue engineering.

Key Stakeholders

  • Biomaterial product manufacturing companies
  • Healthcare service providers (including hospitals & specialty clinics)
  • National and regional research boards and organizations
  • Research & development companies
  • Clinical research organizations (CROs)
  • Healthcare technology companies
  • Biotechnology companies
  • Research laboratories & academic institutes
  • Market research & consulting firms
  • Regulatory bodies

Report Objectives

  • To define, describe, and forecast the Global Biomaterials market based on type and application.
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the Biomaterials market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa
  • To profile the key players in the global Biomaterials market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the Biomaterials market
  • To benchmark players within the Biomaterials market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific Biomaterials market into countries
  • A further breakdown of the Rest of European Biomaterials market into countries
  • A further breakdown of the Rest of Latin American Biomaterials market into countries

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Biomaterials Market

avtar

Joshua

Oct, 2022

What are the recent developments in the Global Biomaterials Market?.

avtar

Alexander

Oct, 2022

Which factors are being the game changer in the global growth of Biomaterials Market?.

avtar

James

Oct, 2022

Which of the geographical segment holds the major share of the Biomaterials Market?.

avtar

Matthew

Jun, 2026

After reviewing the Biomaterials Market dynamics alongside the wound care applications covered in the report, I found the analysis useful for understanding how advanced polymers and regenerative materials are influencing product development strategies across healthcare companies..

avtar

Anthony

Jun, 2026

I went through the report to assess long-term commercial opportunities in the Biomaterials Market, and the segmentation around chronic wound management and bioactive dressings gave me a clearer perspective on future investment priorities..

avtar

Mark

Jun, 2026

The report helped me better understand how the Biomaterials Market is evolving within wound care manufacturing, especially regarding material compatibility, innovation trends, and the growing demand for cost-effective therapeutic solutions..

bottom banner
DMCA.com Protection Status
popup img